We made new categories of health reports available in the new website experience to customers who did not previously have access to them.
Customers who had access to previously available health reports on the older version of our website received these reports in the form of a Reports Archive when they transitioned to the new website experience. A Reports Archive is a place that contains a PDF copy of all of these previously available health reports. However, customers were not able to receive many of our currently available health reports on the new website experience.
Through this update, customers who were eligible for a Report Archive and are on either the V3 or V4 chip will now be able to access and share the Carrier Status* and Health Predispositions* categories within the new format.
Who is included in this update?
You are eligible for this update if:
- You reside in a country in which we offer health reports
- You received or were eligible to receive a Reports Archive
- You were genotyped on our v3 or v4 genotyping chip (You can check your genotyping chip under the Personal Information section of your Settings page.)
What do I need to do?
If you are eligible to receive these reports, you should have received an email notification when they became available in your account. Once you login, you will have the option to opt into the reports if you wish. Please note that some reports (Late-Onset Alzheimer’s Disease*, Parkinson’s Disease*, MUTYH-Associated Polyposis*, and BRCA1/BRCA2 (Selected Variants)*) require an additional opt in to view. You will see this opt in after the general report opt in.
Will these reports be shared?
These reports will be shared with any user with whom you’ve established a Health + Ancestry sharing connection. If you are concerned about sharing your reports with your connections, check Your Connections before opting in. You can cancel or downgrade any Health + Ancestry connections with whom you do not wish to share health reports. Please keep in mind that some reports, including Late-Onset Alzheimer’s Disease*, Parkinson’s Disease*, MUTYH-Associated Polyposis*, and BRCA1/BRCA2 (Selected Variants)*, are never shared with other users regardless of your sharing level.
For more information on Sharing and how to change your settings, see How to Start and Stop Sharing.
How are these different than my Reports Archive?
Many of these reports cover the same or similar variants as the reports included in your archive. However, the formatting and interpretation of results may be different between reports. Your genetic results did not change between reports, but due to differences in the interpretation of results, you may see different overall results in your reports. If you have questions about what you’re seeing, you can check out the article linked from the banner within your account or contact Customer Care.
Will I continue to get updates to my Health Predisposition and Carrier Status Reports?
You may not be eligible for new reports as your sample was processed on an earlier version of our genotyping chip. However, you are welcome to purchase a Chip Upgrade from within your account online to be genotyped on our current chip version. You can learn more about Chip Upgrades here.
*The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The MUTYH-Associated Polyposis Genetic Health Risk Report is indicated for reporting the Y179C and G396D variants in the MUTYH gene and an increased risk for colorectal cancer. The two variants included in this report are most common in people of Northern European descent. These reports do not include variants in other genes linked to hereditary cancers and the absence of variants included in these reports do not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding other genetic health risk reports and carrier status reports, visit https://www.23andme.com/test-info/.